Scientific Due Diligence & Program Assessment

Scientific due diligence and program assessment support informed decision-making during licensing, acquisition, and portfolio evaluation activities. These assessments evaluate scientific rationale, data quality, and development feasibility.

Due diligence activities often involve reviewing nonclinical, clinical, and CMC data to identify strengths, gaps, and risks. Clear, objective assessment supports investment decisions and development planning.

Scientific due diligence provides a structured understanding of program viability and potential challenges.

Scientific due diligence activities commonly include:

• Review of nonclinical and clinical data

• Assessment of development strategy and feasibility

• Identification of scientific and technical risks

• Evaluation of data completeness and quality

• Support for investment and portfolio decisions